In Vitro Susceptibility to Ceftazidime/Avibactam and Comparators in Clinical Isolates of Enterobacterales from Five Latin American Countries

• Egile Nagusiak: Tobias Manuel Appel (Egilea), María Fernanda Mojica (Egilea), Elsa De La Cadena (Egilea), Christian José Pallares (Egilea), Marcela A. Radice (Egilea), Paulo Castañeda-Méndez (Egilea), Diego A. Jaime-Villalón (Egilea), Ana C. Gales (Egilea), José M. Munita (Egilea), María Virginia Villegas (Egilea)
• Formatua: Liburua
• Argitaratua: MDPI AG, 2020-02-01T00:00:00Z.
• Gaiak: article
• Sarrera elektronikoa: Connect to this object online.

<i>Background</i>: High rates of resistance to third-generation cephalosporins and carbapenems in Enterobacterales have been reported in Latin America. Ceftazidime/avibactam (CZA) is the combination of a third-generation cephalosporin and a non-β-lactam β-lactamase inhibitor, which has s...